| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_108e14acad7aeb5b5f02b6b5f6d69557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fdca10276e46f0dcfe4514070b1cdab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d0211f0389012f93500bb14c51decd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac9a93adf94f4be78a7b96aef27a65e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c57a84e8add1dc2939e8c18da4846c3d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2003-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca793e0325c2c604857262a2dc20dba8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d770cf343463a6cfbd4d7a3df119ef81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c232bb96861aecc743732328980d5dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08e827d97aef9732711890975caded72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27e8f219e9c0cf2fc8e7a5b3c6ab7a6a |
| publicationDate |
2006-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7101676-B2 |
| titleOfInvention |
Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA |
| abstract |
The present invention relates to methods of identifying a molecule from a library of molecules that inhibits binding of human immunodeficiency virus nucleocapsid 7 polypeptide (NCp7) to an oligonucleotide which comprises admixing an NCp7 polypeptide with at one labeled HIV-1 psi-site oligonucleotide and an amount of the molecule to be tested under binding conditions; and determining the amount of oligonucleotide bound to the NCp7 polypeptide, wherein a decrease in the amount of oligonucleotide bound in the presence of the molecule compared with the amount of oligonucleotide bound in the absence of the molecule indicates that the molecule inhibits binding of NCp7 polypeptide to the oligonucleotide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009023164-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011151436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603321-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722324-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011015384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9121855-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7888003-B2 |
| priorityDate |
2002-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |